Log In
BCIQ
Print this Print this
 

AAV-S100A1 (formerly InoCor)

  Manage Alerts
Collapse Summary General Information
Company uniQure N.V.
DescriptionAdeno-associated virus (AAV) vector expressing S100 calcium binding protein A1 (S100A1)
Molecular Target S100 calcium binding protein A1 (S100A1)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationCongestive heart failure (CHF)
Indication DetailsTreat congestive heart failure (CHF)
Regulatory Designation
PartnerBristol-Myers Squibb Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

$67.0M

$2,207.0M


 Deals Details
Get a free BioCentury trial today